UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
System Formulary Update
Mirvetuximab Soravtansine-gynx (Elahere)
Situation
Mirvetuximab soravtansine-gynx (Elahere) 100 mg/20 mL (5 mg/mL) SDV for injection was approved for addition to the health system formulary at the February 2023 System Pharmacy and Therapeutics Committee meeting.
Background
The following medications were reviewed:
- Mirvetuximab soravtansine-gynx (Elahere) 100 mg/20 mL (5 mg/mL) SDV for injection
Assessment/Recommendations
System P&T voted to include the following products on the UNC Health System Medication Formulary:
- Mirvetuximab soravtansine-gynx (Elahere) 100 mg/20 mL (5 mg/mL) SDV for injection
Note: Stock of this formulary product may vary at individual entities
Formulary/Epic changes will Go-Live on Tuesday, March 28, 2023.